Wednesday, June 10, 2026

pharma

Boehringer Ingelheim Pty

Boehringer Ingelheim Pty patent portfolio β€” 2 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

North Ryde, AU HQ
TGA registrant Type
Company details
Status
Public
HQ
North Ryde, AU
Programs
0
Drugs
8
Patents
2
Intelligence Β· Patents

Boehringer Ingelheim Pty patents

2 pharmaceutical patents indexed for Boehringer Ingelheim Pty. 1 expire within 24 months.

Boehringer Ingelheim Pty has 2 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months β€” use filters for patent-cliff planning.

Patent portfolio

  1. US 2011293661

    VACCINE STRAINS OF BRACHYSPIRA HYODYSENTERIAE

    Expires Wed Nov 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. AU 2007283667

    Genes and proteins of Brachyspira hyodysenteriae and uses thereof

    Expires Wed Feb 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Boehringer Ingelheim Pty have?

2 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Boehringer Ingelheim Pty patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.